Phagocytosis activator compositions and their use

Details Phagocytosis activator compositions and their use Phagocytosis activator compositions and their use

1997-03-05

1998-07-28

Kishore, Gollamudi S.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514474, A61K 31715, A61K 31375

Patent

active

057863431

ABSTRACT:
A phagocytosis-stimulating composition comprises, and preferably consists essentially of (a) a phagocytosis-stimulating substance, (b) ascorbic acid or a derivative thereof, and (c) a pharmaceutically acceptable carrier. The phagocytosis-stimulating substance suitably can be a yeast cell wall extract, such as beta-(1,3)-D-glucan. The compositions can be administered to animals to stimulate phagocytosis. The composition enhances and prolongs the stimulation of phagocytosis, by supplying ascorbic acid or an ascorbate to help replenish the ascorbate that has been depleted from the phagocytic cells such as macrophages. The composition has pharmaceutical, nutritional, and cosmetic uses, and can be used for prophylactic and therapeutic purposes.

REFERENCES:
patent: 3793052 (1974-02-01), Taylor
patent: 3862336 (1975-01-01), Kofsky et al.
patent: 3889007 (1975-06-01), Gunter et al.
patent: 3943247 (1976-03-01), Komatsu et al.
patent: 3947604 (1976-03-01), McGinley et al.
patent: 4072567 (1978-02-01), Yokobayashi et al.
patent: 4138479 (1979-02-01), Truscheit et al.
patent: 4343784 (1982-08-01), Massot et al.
patent: 4438200 (1984-03-01), Taubman et al.
patent: 4705780 (1987-11-01), Massot et al.
patent: 4739046 (1988-04-01), Di Luzio
patent: 4761402 (1988-08-01), Williams et al.
patent: 4769363 (1988-09-01), Misaki et al.
patent: 4818752 (1989-04-01), Williams et al.
patent: 4833131 (1989-05-01), Williams et al.
patent: 4891220 (1990-01-01), Donzis
patent: 4900722 (1990-02-01), Williams et al.
patent: 4935250 (1990-06-01), Cox
patent: 4962094 (1990-10-01), Jamas et al.
patent: 4965347 (1990-10-01), Misaki et al.
patent: 4992540 (1991-02-01), Jamas et al.
patent: 5032401 (1991-07-01), Jamas et al.
patent: 5057503 (1991-10-01), Czop et al.
patent: 5147862 (1992-09-01), Nikl et al.
patent: 5183667 (1993-02-01), Koch et al.
patent: 5189028 (1993-02-01), Nikl et al.
patent: 5194600 (1993-03-01), Bussey et al.
patent: 5217740 (1993-06-01), Lanter
patent: 5223491 (1993-06-01), Donzis
patent: 5250436 (1993-10-01), Jamas et al.
patent: 5277910 (1994-01-01), Hidvegi
patent: 5397773 (1995-03-01), Donzis
patent: 5401727 (1995-03-01), Rorstad et al.
patent: 5458893 (1995-10-01), Smith
patent: 5474926 (1995-12-01), Harman et al.
patent: 5504079 (1996-04-01), James
patent: 5519009 (1996-05-01), Donzis
patent: 5569670 (1996-10-01), Weischer
patent: 5576015 (1996-11-01), Donzis
Di Luzio, N.R., "Immunopharmacology of glucan: a broad spectrum enhancer of host defense mechanisms", Trends in Pharmacological Sciences, 4:344-347 (1983).
Schoenherr, W.D. et al, "MacroGard.TM.-S--A New Concept for Feeding Starter Pigs", Research, H-102.

Affiliated with

Also associated with

Rating

Phagocytosis activator compositions and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phagocytosis activator compositions and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phagocytosis activator compositions and their use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-23714